RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S. Sep 14, 2017 Life Science
Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis Sep 13, 2017 Life Science
Chinese Genetic Screening Medical Device Developer Basecare Raises $14M Round Sep 12, 2017 Life Science
Borderless Access Launches ‘HealthSight’ – A Programmatic Sampling Suite for Healthcare Research Sep 9, 2017 Life Science
DelMar Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 10-12, 2017 Sep 6, 2017 Life Science
Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement Sep 5, 2017 Life Science
University of British Columbia to Perform Clinical Study on the Cardiovascular and Cognitive Health Effects of Lexaria’s TurboCBDTM. Sep 1, 2017 Life Science
Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix’ Ongoing BETonMACE Trial Aug 29, 2017 Life Science
Lexaria Announces Attendance at Two Cannabis Investment Conferences, and Issues Shares for Debt Aug 29, 2017 Life Science
Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic Transaction Aug 28, 2017 Life Science
Future Farm to Double Size and Ramp Up Baltimore Vertical Farming Project With Second Location Aug 27, 2017 Life Science
